Momenta Pharmaceuticals Inc (MNTA.OQ)

MNTA.OQ on NASDAQ Stock Exchange Global Select Market

1 May 2015
Change (% chg)

$0.73 (+4.18%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for MNTA.OQ


Momenta Pharmaceuticals, Inc. is a biotechnology company operating in three product areas: Complex Generics, Biosimilars and Novel Drugs. The Company’s approach is built around a complex systems analysis platform that it uses to obtain a detailed understanding of complex chemical and biologic systems, design product candidates,... (more)


Beta: 2.23
Market Cap(Mil.): $1,076.93
Shares Outstanding(Mil.): 58.50
Dividend: --
Yield (%): --


  MNTA.OQ Industry Sector
P/E (TTM): -- 188.47 40.23
EPS (TTM): -1.91 -- --
ROI: -37.40 -0.64 15.26
ROE: -41.41 -2.50 16.08
Search Stocks

FDA approves first generic version of Teva's MS drug Copaxone

April 16 - Momenta Pharmaceuticals Inc said the U.S. Food and Drug Administration approved the first generic version of Teva Pharmaceuticals Industries Ltd's top-selling multiple sclerosis drug, Copaxone.

16 Apr 2015


Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: Ford Investor Services, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks